The DIAMET Study: Peripheral and coronary endothelial dysfunction in type 2 diabetic patients - evaluation of reversibility following 3 months of metformin treatment
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Metformin (Primary) ; Gliclazide
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- Acronyms DIAMET
- 05 Oct 2007 Biomarkers information updated
- 04 Oct 2007 Status changed from in progress to discontinued.
- 10 Nov 2005 New trial record.